Zydus Lifesciences trades higher on getting USFDA’s approval for Apixaban Tablets
Zydus Lifesciences is currently trading at Rs. 469.30, up by 3.75 points or 0.81% from its previous closing of Rs. 465.55 on the BSE. The scrip opened at Rs. 469.95 and has touched a high and low of Rs. 472.00 and Rs. 463.35 respectively. So far 6591 shares were traded on the counter. The BSE … Read more
